The present studies were undertaken to examine 1) whether (/-amphetamine sulfate administered to rats well after thrombotic infarction of the vibrissal cortical barrel-field within the primary somatosensory cortex affected the rate and completeness of behavioral recovery and 2) whether a dose-response relation exists between (/-amphetamine sulfate dose and recovery of function. In a learning task requiring sensory-motor integration, 41 rats were trained to perform a motor response in a T-maze consequent to the detection of a vibrissal deflection cue. Once training was complete, unilateral (ft=29) or sham (n = 12) infarction was produced by a noninvasive photochemical technique. After infarction, T-maze performance was assessed repeatedly in rats receiving 2 (n = 10) or4(n=10) mg/kg J-amphetamine sulfate or saline (/i=9) 24 hours prior to testing on days 4, 6, 9, and 11. The sham-operated control rats received (/-amphetamine sulfate (n-1) or no injections (n-5). All three infarcted groups displayed a reliable and sustained behavioral deficit in performance that was not present in the shamoperated control animals. Although the performance of each infarcted group improved over the testing sessions after the first injection, the amphetamine-treated groups improved at a faster rate than the saline-injected group. The results further demonstrated a dose-response effect, with the 4 mg/kg amphetamine group recovering to within preinfarction levels 6-8 days earlier than the 2 mg/kg amphetamine and saline-injected groups. Moreover, both amphetaminetreated groups recovered more completely than the saline-injected group. Quantification of the chronic infarct area revealed no differences among the amphetamine-treated and saline-injected groups. These data provide further evidence of the facilitatory effect of (/-amphetamine sulfate on recovery from brain injury and extend this effect to the enhancement of recovery subsequent to thrombotic infarction of the primary somatosensory cortex. (Stroke 1991^22:648-654) S ince the turn of this century, the remarkable capacity for the brain to recover from cerebral injury, such as stroke, has spurred interest in the use of animal models to study mechanisms of functional recovery and apply them in the clinical setting.1 In recent years, data from animal studies Received August 27, 1990; accepted January 29, 1991. and preliminary clinical findings indicate that some pharmacologic manipulations that alter neurotransmitter (e.g., acetylcholine, •y-amino butyric acid, serotonin, dopamine, and norepinephrine [NE]) function may markedly promote recovery of function following brain injury. 2 One promising agent, the catecholamine agonist amphetamine, has been consistently shown during the past 20 years to reinstate locomotor, righting, and other postural reflexes and enhance recovery from learning and memory deficits induced by electrolytic brain lesions. 2^1 In particular, one recent study found that a single dose of amphetamine given to cats 10 days after unilateral motor cortex ablation...